Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Acadia Healthcare Company, Inc. on November 30, 2016. The filing details significant corporate actions regarding debt refinancing and the completion of a major asset disposition in the United Kingdom.
Key Financial Metrics and Agreements
- Debt Refinancing: The Company entered into a Refinancing Facilities Amendment increasing its revolving credit facility to $500.0 million (from $300.0 million) and reducing its Term Loan A facility to $400.0 million (from $600.6 million).
- Interest Rates: The effective interest rate on Revolving Loans and Term Loan A facilities was lowered by 50 basis points.
- Maturity Extension: The maturity date for the refinancing facilities was extended to November 30, 2021, from February 13, 2019.
- Asset Disposition: The Company sold 21 existing and one de novo behavioral health facilities in the United Kingdom for £320 million (approximately $395 million) in cash.
Material Changes and Covenant Amendments
On November 22, 2016, the Company executed a Tenth Amendment to its Credit Agreement to facilitate the U.K. sale. Key changes included:
- Amending negative covenants to permit the previously announced sale of U.K. facilities.
- Modifying the collateral package to release real property with a fair market value of less than $5,000,000.
- Adjusting investment, indebtedness, and lien baskets.
Outlook, Risks, and Management Commentary
The U.K. Disposition fulfills undertakings made to the Competition and Markets Authority (CMA) to address competition concerns arising from Acadia's acquisition of Priory Group. The filing does not provide specific forward-looking financial guidance, revenue projections, or liquidity metrics beyond the terms of the new credit agreement and the cash proceeds from the sale.
Key Facts for Investor Verification
- Verify the exact cash proceeds received from the U.K. Disposition and any associated transaction costs.
- Confirm the impact of the 50 basis point interest rate reduction on future interest expense.
- Review the full text of the Refinancing Facilities Amendment (Exhibit 10.1) and Tenth Amendment (Exhibit 10.2) for detailed covenant restrictions.
- Assess the strategic rationale for reducing the Term Loan A facility while increasing the revolving credit line.